Auto-Commentary on: "Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells"

被引：3

作者：

de Beauchamp, Lucie ^{[1
]}

Baquero, Pablo ^{[1
]}

Kuntz, Elodie M. ^{[2
]}

Gottlieb, Eyal ^{[2
,3
]}

Helgason, G. Vignir ^{[1
]}

机构：

[1] Univ Glasgow, Coll Med Vet & Life Sci, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Glasgow, Lanark, Scotland

[2] Canc Res UK, Beatson Inst, Garscube Estate,Switchback Rd, Glasgow, Lanark, Scotland

[3] Technion Israel Inst Technol, Fac Med, Technion Integrated Canc Ctr, Haifa, Israel

来源：

MOLECULAR & CELLULAR ONCOLOGY | 2018年 / 5卷 / 01期

关键词：

Cancer stem cells; CML; Metabolism; Imatinib; Leukaemia; OXPHOS; Tyrosine kinase inhibitor; Tigecycline; TCA cycle;

D O I：

10.1080/23723556.2017.1403532

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We have recently uncovered an abnormal increase in mitochondrial oxidative metabolism in therapy-resistant chronic myeloid leukaemia stem cells (LSCs). By simultaneously disrupting mitochondrial respiration and inhibiting BCR-ABL kinase activity using the antibiotic tigecycline and imatinib respectively, we effectively eradicated LSCs and prevented disease relapse in pre-clinical animal models.

引用

页数：3

共 10 条

[1] Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells
Abraham, Sheela A.
Hopcroft, Lisa E. M.
Carrick, Emma
Drotar, Mark E.
Dunn, Karen
Williamson, Andrew J. K.
Korfi, Koorosh
Baquero, Pablo
Park, Laura E.
Scott, Mary T.
Pellicano, Francesca
Pierce, Andrew
Copland, Mhairi
Nourse, Craig
Grimmond, Sean M.
Vetrie, David
Whetton, Anthony D.
Holyoake, Tessa L.
[J]. NATURE, 2016, 534 (7607) : 341 - +
[2] Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells
Bolton-Gillespie, Elisabeth
Schemionek, Mirle
Klein, Hans-Ulrich
Flis, Sylwia
Hoser, Grazyna
Lange, Thoralf
Nieborowska-Skorska, Margaret
Maier, Jacqueline
Kerstiens, Linda
Koptyra, Mateusz
Mueller, Martin C.
Modi, Hardik
Stoklosa, Tomasz
Seferynska, Ilona
Bhatia, Ravi
Holyoake, Tessa L.
Koschmieder, Steffen
Skorski, Tomasz
[J]. BLOOD, 2013, 121 (20) : 4175 - 4183
[3] Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia
Giustacchini, Alice
Thongjuea, Supat
Barkas, Nikolaos
Woll, Petter S.
Povinelli, Benjamin J.
Booth, Christopher A. G.
Sopp, Paul
Norfo, Ruggiero
Rodriguez-Meira, Alba
Ashley, Neil
Jamieson, Lauren
Vyas, Paresh
Anderson, Kristina
Segerstolpe, Asa
Qian, Hong
Olsson-Stromberg, Ulla
Mustjoki, Satu
Sandberg, Rickard
Jacobsen, Sten Eirik W.
Mead, Adam J.
[J]. NATURE MEDICINE, 2017, 23 (06) : 692 - +
[4] The chronic myeloid leukemia stem cell: stemming the tide of persistence
Holyoake, Tessa L.
Vetrie, David
[J]. BLOOD, 2017, 129 (12) : 1595 - 1606
[5] Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
Kuntz, Elodie M.
Baquero, Pablo
Michie, Alison M.
Dunn, Karen
Tardito, Saverio
Holyoake, Tessa L.
Helgason, G. Vignir
Gottlieb, Eyal
[J]. NATURE MEDICINE, 2017, 23 (10) : 1234 - +
[6] BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
Lagadinou, Eleni D.
Sach, Alexander
Callahan, Kevin
Rossi, Randall M.
Neering, Sarah J.
Minhajuddin, Mohammad
Ashton, John M.
Pei, Shanshan
Grose, Valerie
O'Dwyer, Kristen M.
Liesveld, Jane L.
Brookes, Paul S.
Becker, Michael W.
Jordan, Craig T.
[J]. CELL STEM CELL, 2013, 12 (03) : 329 - 341
[7] Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists
Prost, Stephane
Relouzat, Francis
Spentchian, Marc
Ouzegdouh, Yasmine
Saliba, Joseph
Massonnet, Gerald
Beressi, Jean-Paul
Verhoeyen, Els
Raggueneau, Victoria
Maneglier, Benjamin
Castaigne, Sylvie
Chomienne, Christine
Chretien, Stany
Rousselot, Philippe
Leboulch, Philippe
[J]. NATURE, 2015, 525 (7569) : 380 - +
[8] A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia
Reed, Gregory A.
Schiller, Gary J.
Kambhampati, Suman
Tallman, Martin S.
Douer, Dan
Minden, Mark D.
Yee, Karen W.
Gupta, Vikas
Brandwein, Joseph
Jitkova, Yulia
Gronda, Marcela
Hurren, Rose
Shamas-Din, Aisha
Schuh, Andre C.
Schimmer, Aaron D.
[J]. CANCER MEDICINE, 2016, 5 (11): : 3031 - 3040
[9] Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition
Scott, Mary T.
Korfi, Koorosh
Saffrey, Peter
Hopcroft, Lisa E. M.
Kinstrie, Ross
Pellicano, Francesca
Guenther, Carla
Gallipoli, Paolo
Cruz, Michelle
Dunn, Karen
Jorgensen, Heather G.
Cassels, Jennifer E.
Hamilton, Ashley
Crossan, Andrew
Sinclair, Amy
Holyoake, Tessa L.
Vetrie, David
[J]. CANCER DISCOVERY, 2016, 6 (11) : 1248 - 1257
[10] Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
Skrtic, Marko
Sriskanthadevan, Shrivani
Jhas, Bozhena
Gebbia, Marinella
Wang, Xiaoming
Wang, Zezhou
Hurren, Rose
Jitkova, Yulia
Gronda, Marcela
Maclean, Neil
Lai, Courteney K.
Eberhard, Yanina
Bartoszko, Justyna
Spagnuolo, Paul
Rutledge, Angela C.
Datti, Alessandro
Ketela, Troy
Moffat, Jason
Robinson, Brian H.
Cameron, Jessie H.
Wrana, Jeffery
Eaves, Connie J.
Minden, Mark D.
Wang, Jean C. Y.
Dick, John E.
Humphries, Keith
Nislow, Corey
Giaever, Guri
Schimmer, Aaron D.
[J]. CANCER CELL, 2011, 20 (05) : 674 - 688

← 1 →